Search - tctmd.com

Displaying 341 - 360 of 404

Sort: Relevancy | Date

News Daily News

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Yael L. Maxwell

July 12, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Daily News

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

Michael O'Riordan

May 29, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

Yael L. Maxwell

May 15, 2017

News Daily News

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

L.A. McKeown

May 01, 2017

News Daily News

Who Should Get a Statin? Guidelines Don’t Match Up

Michael O'Riordan

April 20, 2017

News Daily News

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Alison Palkhivala

April 11, 2017

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

News Conference News ACC 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Caitlin E. Cox

January 17, 2017

News Daily News

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Caitlin E. Cox

January 12, 2017

News Daily News

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

Yael L. Maxwell

January 04, 2017

Advertisement

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

Who Should Get a Statin? Guidelines Don’t Match Up

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content